SCHEMBL1647491

SCHEMBL1647491

COC(=O)c1cc(C(=O)N2CCCC2)ccc1OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.57
RAB9A P51151 5/20 0.57
HSD17B10 Q99714 2/20 0.56
HPGD P15428 6/20 0.54
ALDH1A1 P00352 4/20 0.54
MAPT P10636 2/20 0.54
ATM Q13315 1/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
LMNA P02545 2/20 0.54
POLB P06746 1/20 0.54
TP53 P04637 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
NPSR1 Q6W5P4 1/20 0.53
HTT P42858 1/20 0.53
APP P05067 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.51
KDM4E B2RXH2 1/20 0.51
ABL1 P00519 1/20 0.51
RIN1 Q13671 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1646608 0.99 HPGD (0.56) NPC1RAB9AHSD17B10HPGDALDH1A1
SCHEMBL1649233 0.91 HPGD (0.56) NPC1RAB9AHSD17B10HPGDALDH1A1
SCHEMBL1647420 0.90 HSD17B10 (0.70) NPC1RAB9AHSD17B10HPGDALDH1A1
SCHEMBL1647813 0.88 ALDH1A1 (0.61) NPC1RAB9AHSD17B10HPGDALDH1A1
SCHEMBL1647511 0.87 ALDH1A1 (0.63) NPC1RAB9AHSD17B10HPGDALDH1A1
SCHEMBL1646582 0.83 RXRA (0.56) NPC1RAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL131382 0.82 MAOB (0.55) NPC1RAB9AHPGDALDH1A1MAPT
SCHEMBL10322800 0.81 HPGD (0.59) NPC1RAB9AHSD17B10HPGDALDH1A1
SCHEMBL1316513 0.81 LRRK2 (0.63) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL1646758 0.80 HSD17B10 (0.57) NPC1RAB9AHSD17B10HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483254-B1 NOVEL COMPOUNDS GLAXO GROUP LTD (GB) 2014-08-13 EP disclosed
US-8778939-B2 Compounds GLAXO GROUP LIMITED (GB) 2014-07-15 US disclosed
EP-2483254-A1 NOVEL COMPOUNDS Glaxo Group Limited (GB) 2012-08-08 EP disclosed
US-20120184553-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-07-19 US disclosed
WO-2011038572-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2011-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184553-A1 NOVEL COMPOUNDS LRRK2, PARK7, PINK1 NPC1 792/4885RAB9A 187/4885HSD17B10 3326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.